Page last updated: 2024-10-20

pyridoxine and Angiogenesis, Pathologic

pyridoxine has been researched along with Angiogenesis, Pathologic in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, CK1
Han, DH1
Ji, YS1
Lee, MS1
Min, CW1
Park, SK1
Kim, SH1
Yun, J1
Kim, HJ1
Kim, KH1
Lee, KT1
Won, JH1
Hong, DS1
Kim, HK1

Other Studies

1 other study available for pyridoxine and Angiogenesis, Pathologic

ArticleYear
Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
    Leukemia research, 2016, Volume: 50

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow Examination; Humans; Immunosuppressive Agent

2016